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Characterization of sodium-calcium exchange in rabbit renal arte-
rioles. Experiments were performed to test the hypothesis that renal
arterioles exhibit Na-Ca exchange capability and that this process is
regulated by protein kinase C (PKC). Glomeruli with attached arterioles
were dissected from rabbit kidney and loaded with fura-2 for measure-
ment of intracellular calcium concentration ([Ca2j1) using microscope-
based photometry. In tissue bathed in Ringer's solution containing 150
mM Na and 1.5 mi Ca2, afferent and efferent arteriolar [Ca2]1
averaged 136 6 and 154 7 nM, respectively. Removal of extracellular
Na increased afferent arteriolar [Ca2*Ii by 70 7 nM, while efferent
arteriolar [Ca2]1 only increased by 39 5 ntvi (P < 0.01 vs. afferent
arteriole). These responses were inhibited by 6 mi Ni2 and required
extracellular Ca2, but were unaffected by 10 1.LM diltiazem. After incuba-
tion in 500 /.LM ouabain, 5 /.LM monensin, and 5 jLM nigericin, [Ca2]
responses to removal of extracellular Na were exaggerated significantly,
averaging 174 50 n in afferent arterioles and 222 82 n in efferent
arterioles (NS vs. afferent arterioles). Moreover, responses to removal of
extracellular Na were enhanced by 100 nM phorbol 12-myristate 13-
acetate, an effect which was blocked by PKC inhibition (25 ni K252b).
These data indicate that both afferent and efferent arterioles express the
Na-Ca exchanger, and that PKC activity impacts on exchange capacity in
these vessels.
Cytosolic calcium concentration ([Ca21) in vascular smooth
muscle is determined by the balance of factors which impact on
net flux of this ion across sarcoplasmic reticulum and sarcolemmal
membranes. Both Ca2 influx across the sarcolemma and release
from intracellular storage sites promote increases in [Ca2], while
Ca2 + sequestration into sarcoplasmic stores and extrusion across
the sarcolemma act to reduce [Ca2]. The primary Ca2 extru-
sion mechanisms that have been identified in vascular smooth
muscle cells are the plasma membrane Ca-ATPase [11 and the
Na-Ca exchanger [2]. Originally described in cardiac muscle [3],
the Na-Ca exchanger found in vascular smooth muscle is an
electrogenic antiport mechanism which transports 1 Ca2 for 3
Na [4]. This "cardiac" isoform of the exchanger can be structur-
ally and functionally distinguished from a similar exchanger found
in retinal rod outer segments, which exhibits an absolute require-
ment for K [5]. Ion transport by the cardiac Na-Ca exchanger
depends on extracellular and intracellular concentrations of both
Na and Ca2 [2, 6—81, membrane potential [9, 101 and a variety
of regulators [11—14]. In particular, stimulation of protein kinase
C (PKC) enhances Na-Ca exchange activity in cultured aortic
smooth muscle cells [13, 15]. Accordingly, recent observations
suggest that PKC stimulation by vasoconstrictor agonists that also
increase [Ca2]1 may lead to phosporylation of the Na-Ca ex-
changer or associated regulatory proteins, ultimately enhancing
exchange activity and facilitating restoration of normal [Ca2]
[16]. Moreover, alterations in vascular smooth muscle Na-Ca
exchange activity may represent one factor that contributes to
development of hypertension [17].
Most excitable and non-excitable cell types studied to date
express the cardiac Na-Ca exchanger, but at varying levels [18].
The primary Na-Ca exchange isoform found in the renal cortex
has a high degree of homology with the cardiac form of the
exchanger [19]. Na-Ca exchange activity has been demonstrated in
proximal, distal and connecting tubules [20—22], as well as in
glomerular mesangial cells [23, 24]. As Na-Ca exchange activity is
generally evident in vascular smooth muscle cells, it is tempting to
assume that this process is involved in regulation of [Ca2] in the
smooth muscle cells of renal arterioles. However, recent observa-
tions indicate that processes governing trans-sarcolemmal Ca2
flux are not uniformly distributed at all sites within the renal
microvasculature. In particular, L-type voltage-gated Ca2 chan-
nels are prominent at preglomerular sites and appear to play only
a minor role in regulation of efferent arteriolar processes [25—28].
As these arteriolar segments may exhibit additional disparities
with regard to mechanisms involved in regulating [Ca2]1, one
cannot presume that a Na-Ca exchange process is expressed in
both afferent and efferent arterioles. Accordingly, the purpose of
the present study was to test the hypothesis that afferent and
efferent arterioles exhibit Na-Ca exchange capability and to
determine if these arteriolar segments differ with regard to this
capability or its regulation.
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Experiments were performed using kidneys obtained from
female New Zealand White rabbits (1 to 2 pounds), primarily
because of the relative ease with which afferent and efferent
arterioles can be obtained by dissection from this species. The
animals were maintained on Prolab rabbit diet (Agway, Inc.,
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Syracuse, NY, USA) and provided water ad libitum. After decap-
itation, the kidneys were removed and cut into 1 to 2 mm coronal
slices. The tissue was placed in Ringer's solution containing 7.1
/LM fura 2-acetoxymethyl ester (fura 2-AM; Molecular Probes
Inc., Eugene, OR, USA). Single glomeruli with associated micro-
vascular structures (afferent or efferent arterioles) and thick
ascending limb were isolated by microdissection using a stereomi-
croscope. Glomeruli were incubated in fura 2-AM for one hour at
room temperature with occasional supplemental applications of
fresh fura 2-AM. Single glomeruli were transferred to a temper-
ature-controlled chamber mounted on the stage of an inverted
microscope equipped with quartz optics. The glomerulus was held
at the bottom of the chamber with a holding pipette, and the free
end of the arteriole was held by gentle suction from a second
pipette to prevent movement during experimental manipulations.
Afferent and efferent arterioles were differentiated based on size
and position relative to the thick ascending limb 1291. The
chamber was warmed to 37°C and Ringer's solution (without fura
2-AM) was continuously exchanged at a rate of 1.5 mI/mm.
Arteriolar [Ca2]1 was measured using dual excitation wave-
length fluorescence microscopy (Photon Technologies, Inc.,
Princeton, NJ, USA), according to methods recently described
[25]. Briefly, light provided by a 75 watt xenon light source was
alternated between excitation monochrometers which were set at
350 and 380 nm, selected based upon wavelength scans using fura
2 pentapotassium salt (Molecular Probes). The illumination path-
way contained a dichroic mirror and a x40 oil-immersion objec-
tive (numerical aperture 1.30). An adjustable optical sampling
window was positioned over the arteriole and emission fluores-
cence (10 nm bandpass centered at 510 nm) was collected using a
photometer system. Fluorescence measurements were collected at
a rate of 20 points/second, and data were stored and processed
using Photon Technologies software. Arterioles which displayed
emitted fluorescence intensities <400,000 counts/sec at either
excitation wavelength were excluded from the study.
Accurate in situ calibration of fura-2 responses is problematic in
vascular smooth muscle cells because of the efficient Ca2 extru-
sion mechanisms present in these cells [30, 31]. However, there is
close agreement between in vitro and in situ calibrations when
measures are employed to assure that the cytosol is suitably
equilibrated with extracellular Ca2 [321, indicating that in vitro
calibration constitutes an adequate method for deriving [Ca2I1
from fura-2 responses determined in situ. Therefore, the present
studies utilized an in vitro calibration procedure performed at
37°C and pH 7.05 using a solution approximating the ionic
strength and composition of cytoplasm [33]. The calibration
solution contained 115 mr'i KC1, 20 mi NaCl, 10 mM morpholi-
nopropanesulfonic acid (MOPS), 1.1 mrvt MgCl2, 1 /xM fura-2
pentapotassium salt, and either 3.0 m'vi CaCl2 or 3 m ethylene
glycol-bis(p-aminoethyl ether) N,N,N',N'-tetraacetic acid
(EGTA). Based on this calibration procedure, arteriolar [Ca2]
was determined as:
[2f] = Kd[(R — V x R,,,)/(V x R,, — R)](Sf2/Sb2)
where Kd is the effective dissociation constant of fura-2 (224 nM)
[33], R is the 350-to-380 ratio, V is the viscosity correction factor
[341, Rmin and Rmax are the 350-to-380 nm ratios in the absence
and presence of saturating levels of Ca2, respectively, and S2
and Sb2 are the 380 nm signals in the absence and presence of
saturating Ca2, respectively. The viscosity correction factor was
assigned a value of 0.85, thus compensating for the usual effect of
cytoplasmic viscosity and related factors to reduce fura-2 fluores-
cence by 15% compared with simple solutions [34].
Solutions and drugs
Arterioles were bathed continuously in oxygenated Ringer's
solution (pH 7.40) composed of 148.0 mM NaC1, 5.0 mrvi KC1, 1.0
mM MgSO, 1.6 mr't Na2HPO4, 0.4 mM NaH2PO4, 1.5 mM CaCI2
and 5.0 mivi d-glucose. All experimental manipulations employed
specific modifications in the composition of this basic Ringer's
solution. Reductions in the [Na] of this solution were achieved
by isosmotic replacement of NaCl with N-methyl-D-glucamine
(NMDG). The nominally Nat-free Ringer's solution prepared by
complete substitution of NMDG for NaCl contained only that
amount of Na associated with the phosphate buffer system.
Ca2-free Ringer's solution was prepared by equimolar substitu-
tion of EGTA for CaCI2. In some experiments, 6 mM NiCI2 was
added to the Ringer's solution. Diltiazem HC1 (10 xM; Marion
Merrell Dow, Kansas City, MO, USA) was utilized to block Ca2
influx via voltage-gated channels. Since Na-Ca exchange activity
displays a sigmoidal dependence on [Na] [35], some experi-
ments employed combined treatment with 500 /.LM ouabain, 5 xM
monensin and 5 xM nigericin (Sigma Chemicals, St. Louis, MO,
USA) to achieve increased {Na]1. In other experiments, phorbol
12-myristate 13-acetate (PMA, 100 nM; Sigma) was used to
activate PKC [36] and 25 ni't K252b (LC Laboratories, Woburn,
MA, USA) was utilized as an inhibitor of PKC activity [37].
Statistical analysis
Data are expressed as the mean SE. Except where noted,
responses to changes in bath [Na] are reported as the peak
(maximal) change in [Ca2]1. Statistical significance was estab-
lished using Student's paired or unpaired t-test. Significance was
accepted at P < 0.05.
Results
Baseline [Ca2]1 averaged 136 6 nM (N = 56) in afferent
arterioles and was significantly higher in efferent arterioles (154
7 nivi, N = 58, P < 0.03). Figure 1 illustrates typical changes in
afferent and efferent arteriolar [Ca2] which accompanied expo-
sure to the nominally Nat-free bathing solution. This manipula-
tion evoked a transient [Ca2]1 spike and subsequent partial
recovery toward baseline [Ca2j, despite continued exposure to
the Nat-free solution. Exposure to the Natfree bathing solution
significantly increased [Ca2]1 by 70 7 nM (N = 35) in afferent
arterioles and 39 5 nM (N = 34) in efferent arterioles. The
magnitude of the afferent arteriolar [Ca2]1 spike evoked by the
Nat-free bath significantly exceeded that observed in efferent
arterioles (P < 0.01); however, in accord with the disparity in
basal [Ca2]1, the actual peak [Ca2]1 value achieved was similar
in afferent (208 13 nM) and efferent arterioles (193 11 nM). In
the continued absence of extracellular Nat, most vessels dis-
played a partial recovery of [Ca2]1 to levels that remained
significantly elevated above baseline in both afferent (188 12
nM) and efferent arterioles (188 13 nM). Finally, return to the
normal (150 mrvi Na) bathing solution restored [Ca2] to levels
that did not differ significantly from baseline in either vessel
segment (afferent, 129 7 nM; efferent, 148 10 nM).
Figure 2 shows the effects of graded reductions in extracellular
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Na concentration ([Na]) on afferent and efferent arteriolar
[Ca2]1. Reducing [Na]e from 150 to 50 mivt increased afferent
arteriolar [Ca2}1 from 149 11 to 190 16 nM (P < 0.01, N =
6), and subsequent exposure to the nominally Na-free Ringer's
solution caused a further increase in [Ca2] to 235 25 nM (P <
0.01). Efferent arteriolar [Ca2I1 increased significantly from
164 28 to 178 30 and 194 33 nM (N = 7) when Na]e was
reduced in a stepwise manner from 150 to 50 and 0 m,
respectively. Although there was an inverse relationship between
[Na] and [Ca2]1 in both afferent and efferent arterioles,
afferent arterioles were more responsive than efferent arterioles
to graded reductions in [Na] (P < 0.05).
Further experiments probed the effect of cytosolic Na loading
on the response to Nat-free bathing solution. [Ca2]1 responses
to the nominally Na-free Ringer's solution were determined in
arterioles which had been incubated (5 mm) in Ringer's solution
containing 500 j.tM ouabain, 5 .LM monensin, and 5 fLM nigericin
(OMN). Incubation in OMN increased afferent arteriolar {Ca2]1
from 130 8 to 174 6 nr.t (N = 6). Effererit arteriolar [Ca2}
was similarly increased from 112 12 to 160 17 nM (N = 5) by
the OMN treatment. In the continued presence of OMN, expo-
sure to the Nat-free Ringer's solution evoked marked increases
in [Ca21 that averaged 174 49 nM in afferent arterioles and
221 82 n in efferent arterioles. These responses significantly
exceeded those observed in untreated afferent (P < 0.02) or
efferent (P < 0.001) arterioles, reflecting amplification of the
response to Nat-free Ringer's solution after treatment with
OMN.
Afferent and efferent arteriolar [Ca2]1 responses to removal of
extracellular Na were abolished when this manipulation was
imposed in the absence of extracellular Ca2t Exposure of
afferent arterioles to Ca2-free Ringer's solution reduced [Ca2]1
from 105 12 to 66 9 nM. In the continued absence of
extracellular Ca2, removal of extracellular Na failed to alter
afferent arteriolar Ca2] significantly (—1 2 nM; N = 5).
Similarly, exposure to the Ca2-free Ringer's solution reduced
efferent arteriolar [Ca2J1 from 127 7 to 77 7 nM, and
subsequent removal of extracellular Na did not alter [Ca2]1
significantly (4 2 nM; N = 6). Therefore, the increase in [Ca2]1
that accompanied exposure to a Na-free bathing solution re-
quired extracellular Ca24, implicating Ca2 influx in the response.
Additional experiments utilized Ni2 as a nonspecific inhibitor
of Na-Ca exchange. Exposure to Ringer's solution containing 6
mM Ni2 reduced [Ca2]1 by approximately 45% in both afferent
arterioles (from 88 15 to 49 4 nM; N = 3) and efferent
arterioles (from 128 13 to 69 9 nM; N = 5). Subsequent
exposure to Na-free Ringer's solution in the continued presence
of Ni2 failed to increase [Ca2] significantly in either arteriolar
segment (afferent, —2 4 ni; efferent, 3 2 nM). Return to the
normal Ringer's solution restored baseline [Ca2]1 and respon-
siveness to removal of extracellular Nat
To rule out any participation of voltage-gated calcium channels
in the response to removal of bath Nat, [Ca2}1 responses to the
nominally Na-free bathing solution were determined in afferent
arterioles which had been incubated (5 mm) in Ringer's solution
containing 10 xM diltiazem. Preliminary observations verified that
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Fig. 2. Arteriolar [Ca2J responses to graded reductions in [Na]. *P <
0.05 vs. 150 mM [Na]; P < 0.05, allerent vs. efferent. Symbols are: (I)
afferent arteriole, N = 6; (0) efferent arteriole, N = 7.
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Fig. 1. Typical arteriolar [Ca27, responses to the nominally Natfree
bathing solution. A. Afferent arteriole. B. Efferent arteriole. Arrows denote
changes in [Na], from 150 to 0 to 150 mM.
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Fig. 3. Influence of protein kinase C activity on arteriolar [Ca2 47 responses
to Na-free bathing solution. A. Typical responses (afferent arteriole) to
Na-free Ringers solution before and after exposure to 100 nM PMA. B.
Mean responses of afferent and efferent arterioles to Na-free bathing
solution before (ta, control) and after treatment with either 100 ni PMA
(•) or 100 nM PMA plus 25 nsi K-252b (). P < 0.05 vs. control
response.
diltiazem treatment reversed the afferent arteriolar [Ca2]1 re-
sponse to membrane depolarization (40 m bath K, prepared by
substitution for Na in the Ringer's solution). Diltiazem treat-
ment did not alter afferent arteriolar baseline [Ca2]1 (control,
123 3 nrvi; diltiazem, 117 6 nM). Moreover, the nominally
Nat-free Ringer's solution increased afferent arteriolar [Ca2], by
62 3 nvi under control conditions and by 60 9 nM during
diltiazem treatment (N = 4). Thus, diltiazem treatment failed to
significantly alter the afferent arteriolar [Ca2] response to
removal of extracellular Nat
Figure 3 illustrates the impact of PKC activity on responses to
removal of extracellular Nat Arterioles were subjected to the
Nat-free Ringer's solution both before and after 30 minutes of
incubation with either 100 nM PMA or PMA plus 25 nM K252b. In
these experiments, baseline [Ca2]1 averaged 106 13 nvt (N =
11) in afferent arterioles and 127 22 nM (N = 10) in efferent
arterioles. PMA treatment altered neither afferent nor efferent
arteriolar baseline [Ca2]1. Efferent arteriolar [Ca2] was also
unaffected by incubation in the PMA+K252b mixture; however,
this treatment reduced baseline afferent arteriolar [Ca2]1 to 65
9 flM (P < 0.05). Incubation in PMA significantly enhanced
afferent arteriolar [Ca2]1 responses to removal of bath Na from
77 26 to 135 35 flM (N = 7; P < 0.05). Therefore, PMA
T
evoked a 91 40% potentiation of afferent arteriolar responses to
—
the Nat-free Ringer's solution. In contrast, exposure to the
nominally Nat-free bathing solution increased afferent arteriolar
[Ca2]1 by 57 9 flM before and 17 3 nM after treatment with
the PMA+K252b mixture (N = 4; P < 0.02). Therefore, K252b
prevented PMA-induced enhancement of the afferent arteriolar
[Ca2]1 response to the Na-free bathing solution. In fact, K252b
attenuated the impact of the Na-free bathing solution on
afferent arteriolar [Ca2]1 by 68 6%, despite the presence of
PMA.
PMA exerted a similar impact on efferent arteriolar function
(Fig. 3). Efferent arteriolar [Ca2]1 responses to removal of bath
Na averaged 37 11 flM before and 93 25 nM after PMA
treatment (N = 6;P < 0.05), reflecting a 179 64% enhancement
of the response. However, efferent responses to removal of
extracellular Na were not altered significantly by incubation in
the PMA+K252b mixture (48 17 nM increase in [Ca2] before
and 37 12 nM increase after treatment; N = 4). K252b
prevented PMA-induced enhancement of the efferent arteriolar
[Ca2]1 response to the Na-free bathing solution.
Discussion
Previous studies from our laboratory [25] and others [38—401
have utilized fura-2 to measure [Ca2] in isolated renal arterioles.
Use of a photometry-based method for monitoring fura-2 re-
sponses in intact renal arterioles relies on the validity of several
assumptions, which we have considered in detail previously [25].
Of primary importance is the assumption that vascular smooth
muscle cells provide the major source of fura-2 fluorescence
emissions in this experimental setting. Two factors support this
contention. First, since fura-2AM was introduced from the ablu-
minal aspect of the vessels, its diffusion to the endothelial layer
was presumed to be limited by the presence of complete layers of
vascular smooth muscle cells in rabbit renal arterioles [41].
Secondly, even if significant endothelial loading of fura-2 was
achieved, fluorescence emissions from this cell population were
probably eclipsed by those originating from the larger mass of
vascular smooth muscle cells. Therefore, it is likely that [Ca2I1
responses detected under these experimental conditions reflect
primarily the behavior of arteriolar vascular smooth muscle cells.
The present study exploited the impact of alterations in trans-
membrane Na gradient on [Ca2] to probe the Na-Ca exchange
capability of renal arterioles. Under normal conditions, the dcc-
trochemical gradients existing across the vascular smooth muscle
cell membrane favor influx of both Na and Ca2. Removal of
extracellular Na, with maintained [Ca2], establishes a situation
in which the electrochemical gradient across the cell membrane
favors Na efflux and Ca2 influx. Although the cell membrane is
relatively impermeable to these ions, Na efflux and accompany-
ing Ca2 influx occurs readily in cells that express the Na-Ca
exchanger. Accordingly, studies using aortic vascular smooth
muscle have documented that replacement of extracellular Na +
with other monovalent ions evokes 22Na efflux [42], 45Ca2
influx [13, 35], increases in [Ca2] [13, 43, 44], and increases in
active tension [2]. Such experiments typically utilize K, Lit,
choline or NMDG as substitutes for extracellular Nat However,
increases in [K]e evoke membrane depolarization and elevation
of afferent arteriolar [Ca2]1 via opening of voltage-gated chan-
nels [25], while choline has been reported to inhibit Na-Ca
exchange to some extent [45]. Moreover, Li can be transported
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across cell membranes via the Na-H antiporter [43]. Therefore,
the present study utilized NMDG as a substitute for extracellular
Nat The data reveal that replacement of extracellular Na with
NMDG elicits increases in afferent and efferent arteriolar [Ca2],
responses that are consistent with reverse-mode Na-Ca exchange.
Typical renal arteriolar responses to removal of bath Na
involved a rapid and marked elevation in [Ca2I1, followed by a
partial recovery of [Ca2]1 toward baseline values. This recovery
occurred despite the continued absence of extracellular Nat, and
has been termed Nat-independent recovery. This process cannot
reflect operation of the Na-Ca exchanger in the Ca2-extrusion
mode (the so-called forward-mode), since this would require
extracellular Nat Nat-independent recovery of [Ca2] toward
baseline after achieving the peak response has been attributed to
dissipation of the Na gradient [43], but may also reflect Ca2
sequestration or extrusion by Ca-ATPases that are known to
exhibit high activity in smooth muscle cells [1]. Na-independent
recovery of renal arteriolar [Ca2]1 after removal of bath Na was
incomplete within the time frame of our experiments, similar to
the previously reported behavior of cultured aortic smooth muscle
cells [44]. Cardiac myocytes studied by the whole-cell patch clamp
technique seem to require extracellular Na for complete return
of [Ca2]1 to baseline levels following depolarization-induced
increases [46]. Indeed, we usually observed a complete return of
arteriolar [Ca2]1 to baseline levels only upon reintroduction of
extracellular Nat This Na-dependent recovery is suggestive of
the Na-Ca exchange mechanism working in the forward mode
(Ca2 extrusion coupled to Na influx). These observations
indicate that Ca-ATPases are not capable of fully compensating
for marked increases in [Ca2] in several cell types, including
renal arterioles, and support the contention that the Na-Ca
exchanger normally plays a significant role in restoring [Ca2] to
basal levels during recovery from vascular smooth muscle activa-
tion [44, 47—49].
Ion transport by the Na-Ca exchanger in Na-1oaded aortic
smooth muscle and small mesenteric arteries depends in part on
[Na]e, such that 45Ca2 uptake [42], 22Na efflux [501, and
[Ca2]1 [43, 44, 50] are inversely related to [Na] within the
range of 0 to 140 m. Results of the present study confirm that
renal arteriolar [Ca2]1 increases in proportion to imposed reduc-
tions in [Na]e. As these effects reflect the impact of alterations in
the transmembrane Na gradient, Ca2 entry via a Na-Ca ex-
changer should be enhanced not only by reducing [Na1, but also
by raising [Na]1. Numerous studies have documented enhanced
responses to removal of extracellular Na in smooth muscle cells
that had been Na-loaded [35, 42—44, 50]. The most striking
responses to removal of extracellular Na have been observed
when total cell Na was markedly increased by prior exposure to
ouabain in the presence of ionophores [42]. Accordingly, the
present study employed a combined treatment with ouabain
(Na-K-ATPase inhibitor), monensin (Na ionophore) and nigeri-
cm (monovalent cation ionophore) to Na-load renal arterioles.
This treatment can be expected to result in membrane depolar-
ization due to inhibition of the electrogenic pump and loss of the
K gradient, as well as increased [Na]1 [42, 51]. OMN treatment
evoked an increase in basal [Ca2I1 in both afferent and efferent
arterioles. This response may develop through a combination of
mechanisms. In addition to increasing the [Na]1, ouabain has
been postulated to shift the dependence of Na-Ca exchange
activity on [Na]1 in a manner that activates the Ca2 influx mode
of the mechanism [52]. Both of these effects should favor an
increase in basal [Ca2] during OMN treatment of renal arte-
rioles in the present study. Also, some data indicate that increases
in [Na]1 stimulate Ca2 release from the sarcoplasmic reticulum
[531. Finally, the membrane depolarization could lead to Ca2
influx via voltage-gated calcium channels in afferent arterioles
[25], thus contributing to an increase in basal [Ca2]1. Although
the results of the present study do not distinguish between the
potential mechanisms responsible for the increase in basal [Ca2]1
evoked by OMN treatment, the enhanced [Ca2]1 response to
removal of bath Na under these conditions likely results primar-
ily from the Na-loading effect of ouabain and the ionophores.
This observation is consistent with the well-documented depen-
dence of Na-Ca exchange activity on [Na]1 and supports the
postulate that renal arterioles express this antiport mechanism.
The renal arteriolar response to removal of extracellular Na
was demonstrable (in fact, enhanced) during the sustained mem-
brane depolarization associated with ouabain treatment [51]. This
indicates that changes in the Na gradient do not underlie the
effect of Na-free bathing solutions on [Ca2]1 via changes in
membrane potential and opening of voltage-gated calcium chan-
nels. Nevertheless, since voltage-gated calcium channels have a
prominent effect on renal afferent (but not efferent) arteriolar
function [25—28], we confirmed that afferent arteriolar [Ca2]1
responses to removal of extracellular Na were sustained during
diltiazem treatment. This observation is in agreement with nu-
merous reports that Na-Ca exchange activity in vascular smooth
muscle is insensitive to blockers of voltage-gated calcium channels
[6, 13, 45, 49].
An additional requirement for operation of the Na-Ca ex-
change mechanism in renal arterioles is a dependence upon the
transmembrane Ca2 gradient. To address this issue, arteriolar
[Ca2]1 responses to removal of extracellular Na were assessed
in a Ca2-free bathing solution. As we have reported previously
[25], removal of bath calcium reduced [Ca2]1 in both vessel
segments. If Na-Ca exchange is involved in extruding Ca2 in the
resting state, removing bath Ca2 should increase the ease with
which this occurs (by reversing the normal Ca2 gradient to favor
Ca2 extrusion), thus reducing [Ca2]1. Therefore, the exchanger
may underlie, at least in part, the decrease in [Ca2] observed
when Ca2 is removed from the bathing solution. In the continued
absence of extracellular Ca2, removal of extracellular Na did
not significantly alter [Ca2]1, indicating that the increase in
[Ca2]1 normally evoked by this maneuver reflects Ca2 influx.
This extracellular Ca2-dependent nature of the [Ca2]1 response
to removal of extracellular Na is consistent with reverse-mode
operation of the Na-Ca exchanger, extruding Na from the cell in
exchange for Ca2t
Attempts to assess the role of Na-Ca exchange in intracellular
Ca2 homeostasis continue to be limited by the lack of a specific
inhibitor for this transport process. The so-called Exchanger
Inhibitory Peptide has been reported to act as a specific blocker of
Na-Ca exchange activity in guinea pig ventricular myocytes [54];
however, this substance must be introduced into the intracellular
compartment by injection or by dialysis from a patch pipette, and
thus is not useful in multicellular preparations such as isolated
arterioles. Amiloride derivatives have been reported to act as
somewhat less specific inhibitors of Na-Ca exchange activity [10,
55, 56]; however, their autofluorescent properties interfere with
fura-2 measurements of [Ca2]L. Certain trivalent and divalent
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cations (La3, Ni2, Cd2) block Na-Ca exchange in a variety of
experimental settings [45, 57]. Among these cations, Ni2 has
been shown to inhibit the Na-Ca exchange most selectively and
with little effect on background current in ventricular myocytes
studied in the voltage-clamp mode [57]. As Ni2 acts mainly to
compete with Ca2 for transport across the cell membrane, the
observed effect of extracellular Ni2 to inhibit the renal arteriolar
[Ca2] response to a Na-free bathing solution implicates Ca2
influx via the Na-Ca exchanger in the normal response to this
maneuver. This conclusion is in accord with previous observations
in aortic vascular smooth muscle cells [44], although Ni2 may
influence transmembrane Ca2 flux via a variety of pathways (as
evidenced by the reduction in [Ca21 evoked by Ni2 under
baseline conditions).
Although both afferent and efferent arterioles exhibited behav-
ior consistent with expression of the Na-Ca exchange mechanism,
there appeared to be some quantitative differences in these
responses. Afferent arterioles were more sensitive than efferent
arterioles to manipulation of [Na]e, suggesting that Na-Ca
exchange capability might be greater at preglomerular sites.
However, we cannot rule out the possibility that this phenomenon
reflects the observed disparities in basal [Ca2] or as yet unde-
fined differences in membrane potential, [Na]1 or other factors
that might impact on exchanger activity at the two microvascular
sites.
One factor known to modulate Na-Ca exchange function in
aortic smooth muscle is PKC activity [13, 15]. Therefore, to
further substantiate our contention that the phenomena observed
in the present study reflect functional expression of the Na-Ca
exchanger in renal arterioles, we assessed the impact of PKC
activity on the response to removal of extracellular Nat Involve-
ment of PKC in regulation of renal arteriolar Na-Ca exchange
activity is supported by our observation that the [Ca2] response
to removal of extracellular Na + was augmented by acute PMA
treatment. The primary effects of acute treatment with PMA and
related phorbol esters involve activation of PKC [36]. However, to
rule out any nonspecific (PKC-independent) effect of PMA
treatment on Na-Ca exchange activity in our experimental setting,
additional studies employed co-incubation of arterioles in a
PMA+K252b mixture. K252b inhibits PKC activity with a potency
several orders of magnitude greater than H-7, trifluoperazine or
chlorpromazine [37, 58]. Since PMA did not facilitate arteriolar
responses to removal of extracellular Na in the presence of
K252b, it appears that the effect of PMA on the Na-Ca exchange
capability of renal arterioles involves activation of PKC. More-
over, the observation that combined PMA+K252b treatment
significantly attenuated the afferent arteriolar response to removal
of bath Na (relative to untreated tissue) suggests that basal PKC
activity may be sufficient to impact on Na-Ca exchange activity
under control conditions. The mechanism through which PKC
activity modulates Na-Ca exchange activity remains speculative,
but may involve PKC-dependent phosporylation of the exchanger
or associated regulatory proteins [161. In any case, our observation
that PKC activity influences Na-Ca exchange capacity in renal
arterioles is consistent with previously reported properties of the
exchange mechanism in vascular smooth muscle cells [13, 15].
Although available evidence indicates that PKC activation gener-
ally promotes renal vasoconstriction [59, 601, these observations
suggest that a secondary effect of PKC activation may involve
facilitation of Ca2 extrusion via the Na-Ca exchanger. Indeed,
angiotensin II and norepinephrine have been postulated to facil-
itate Na-Ca exchange in aortic myocytes by a mechanism involving
PKC activation [16, 91. Therefore, PKC activation of the Na-Ca
exchanger may contribute to recovery of arteriolar [Ca2J1 after
agonist-induced vasoconstriction. Taken together, these observa-
tions suggest that either acute (agonist-stimulated) or chronic
(disease-associated) alterations in PKC activity could impact on
renal arteriolar function by altering the participation of Na-Ca
exchange in regulation of [Ca2]1 and, hence, smooth muscle tone.
In summary, renal arteriolar [Ca2] increased in response to
reductions in [Na]e through a mechanism that required extra-
cellular Ca2t This response was accentuated by pretreatment
with OMN to increase [Na]1 and was blocked by Ni2, a
competitive inhibitor of Na-Ca exchange. These results support
the hypothesis that renal afferent and efferent arterioles express a
Na-dependent Ca2 regulatory mechanism, evidently the Na-Ca
exchanger. Moreover, activation of Na-Ca exchange was pro-
moted by phorbol esters, suggesting that PKC activity modulates
the Na-Ca exchange capacity in renal arterioles. Further studies
are necessary to discern the physiological and pathophysiological
relevance of these processes and their impact on arteriolar
resistance and glomerular function.
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